Comparative efficacy and safety of six antidepressants and anticonvulsants in painful diabetic neuropathy: a network meta-analysis.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Pain Physician

• Publication date

  2013-11-01

• Fields of study

  Medicine

• Identifiers
  PMID 24284851
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Evaluation of efficacy and safety of gabapentin, duloxetine, and pregabalin in patients with painful diabetic peripheral neuropathy

  2012cited by this paper
• Randomized, Placebo-Controlled Comparison of Amitriptyline, Duloxetine, and Pregabalin in Patients With Chronic Diabetic Peripheral Neuropathic Pain

  2012cited by this paper
• A gastroretentive gabapentin formulation for the treatment of painful diabetic peripheral neuropathy: efficacy and tolerability in a double-blind, randomized, controlled clinical trial.

  2012cited by this paper
• Prevalence and Characteristics of Painful Diabetic Neuropathy in a Large Community-Based Diabetic Population in the U.K.

  2011cited by this paper
• Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial.

  2011cited by this paper
• Evidence-based guideline: Treatment of painful diabetic neuropathy

  2011cited by this paper
• Efficacy and safety of pregabalin for treating neuropathic pain associated with diabetic peripheral neuropathy: a 14 week, randomized, double‐blind, placebo‐controlled trial

  2011cited by this paper
• NICE DSU Technical Support Document 2: A Generalised Linear Modelling Framework for Pairwise and Network Meta-Analysis of Randomised Controlled Trials

  2011cited by this paper
• Duloxetine, pregabalin, and duloxetine plus gabapentin for diabetic peripheral neuropathic pain management in patients with inadequate pain response to gabapentin: an open-label, randomized, noninferiority comparison.

  2011cited by this paper
• A stochastic multicriteria model for evidence‐based decision making in drug benefit‐risk analysis

  2011cited by this paper
• Evidence‐based Guideline: Treatment of Painful Diabetic Neuropathy

  2011influential reference
• A Comparative Evaluation of Amitriptyline and Duloxetine in Painful Diabetic Neuropathy

  2011cited by this paper
• Duloxetine versus placebo in the treatment of patients with diabetic neuropathic pain in China.

  2010cited by this paper
• Diabetic Neuropathy

  2010cited by this paper
• Amitriptyline vs. pregabalin in painful diabetic neuropathy: a randomized double blind clinical trial

  2009cited by this paper
• Painful diabetic neuropathy: epidemiology, natural history, early diagnosis, and treatment options.

  2008cited by this paper
• The effect of venlafaxine HCl on painful peripheral diabetic neuropathy in patients with type 2 diabetes mellitus.

  2008influential reference
• Pregabalin for relief of neuropathic pain associated with diabetic neuropathy: A randomized, double‐blind study

  2008cited by this paper
• Efficacy and safety of pregabalin 600 mg/d for treating painful diabetic peripheral neuropathy: A double-blind placebo-controlled trial

  2008cited by this paper
• Lamotrigine for treatment of pain associated with diabetic neuropathy: Results of two randomized, double‐blind, placebo‐controlled studies

  2007cited by this paper
• Effects of treatments for symptoms of painful diabetic neuropathy: systematic review

  2007cited by this paper
• A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain

  2006cited by this paper
• A double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain.

  2005cited by this paper
• Duloxetine vs. placebo in patients with painful diabetic neuropathy

  2005cited by this paper
• Pain severity in diabetic peripheral neuropathy is associated with patient functioning, symptom levels of anxiety and depression, and sleep.

  2005cited by this paper
• Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double‐blind, placebo‐controlled trial

  2004cited by this paper
• Chronic painful peripheral neuropathy in an urban community: a controlled comparison of people with and without diabetes

  2004cited by this paper
• Venlafaxine extended release in the treatment of painful diabetic neuropathy: a double‐blind, placebo‐controlled study

  2004cited by this paper
• Pregabalin relieves symptoms of painful diabetic neuropathy

  2004cited by this paper
• Epidemiology and Impact on Quality of Life of Postherpetic Neuralgia and Painful Diabetic Neuropathy

  2002cited by this paper
• Positive neuropathic sensory symptoms as endpoints in diabetic neuropathy trials.

  2001cited by this paper
• Gabapentin and Venlafaxine for the Treatment of Painful Diabetic Neuropathy

  2001cited by this paper
• Positive neuropathic sensory symptoms as endpoints in diabetic neuropathy trials

  2001cited by this paper
• Gabapentin vs. amitriptyline in painful diabetic neuropathy: an open-label pilot study.

  2000cited by this paper
• Gabapentin therapy for diabetic neuropathic pain.

  2000cited by this paper
• Antidepressants and anticonvulsants for diabetic neuropathy and postherpetic neuralgia: a quantitative systematic review.

  2000cited by this paper
• Gabapentin for the Symptomatic Treatment of Painful Neuropathy in Patients With Diabetes Mellitus: a Randomized Controlled Trial

  1999cited by this paper
• Gabapentin in the treatment of painful diabetic neuropathy: a placebo controlled, double blind, crossover trial

  1999cited by this paper
• Randomized double-blind study comparing the efficacy of gabapentin with amitriptyline on diabetic peripheral neuropathy pain.

  1999cited by this paper
• Size is everything – large amounts of information are needed to overcome random effects in estimating direction and magnitude of treatment effects

  1998cited by this paper
• Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial.

  1998cited by this paper
• Risk Factors For Distal Symmetric Neuropathy in NIDDM: The San Luis Valley Diabetes Study

  1994cited by this paper
• C O M M E N T a R Y Open Access

  year unknowncited by this paper

• Tolerability and Efficacy of Duloxetine Compared to Amitriptyline in Women With Chronic Pelvic Pain Syndrome: Findings From a Clinical Trial

  2025cites this paper
• Diabetic Peripheral Neuropathy: New Diagnostics and Treatment Perspectives

  2025cites this paper
• Update on Treating Painful Diabetic Peripheral Neuropathy: A Review of Current US Guidelines with a Focus on the Most Recently Approved Management Options

  2024cites this paper
• Widespread pain phenotypes impact treatment efficacy results in randomized clinical trials for interstitial cystitis/bladder pain syndrome: a Multidisciplinary Approach to the Study of Chronic Pelvic Pain network study

  2024cites this paper
• Widespread Pain Phenotypes Impact Treatment Efficacy Results in Randomized Clinical Trials for Interstitial Cystitis/Bladder Pain Syndrome: A MAPP Network Study

  2023cites this paper
• Natural molecules as promising players against diabetic peripheral neuropathy: an emerging nutraceutical approach

  2023cites this paper
• Exploring the Potent Combination of Quercetin-Boronic Acid, Epalrestat, and Urea Containing Nanoethosomal Keratolytic Gel for the Treatment of Diabetic Neuropathic Pain: In Vitro and In Vivo Studies.

  2023cites this paper
• Pharmacological and Nonpharmacological Treatments for Painful Diabetic Peripheral Neuropathy

  2023cites this paper
• Efficacy and safety of different drug treatments in patients with spinal-cord injury-related neuropathic pain: a network meta-analysis

  2022cites this paper
• Pharmacotherapy of Painful Diabetic Neuropathy: A Clinical Update

  2022cites this paper
• Comparison of the clinical effectiveness of treatments for aromatase inhibitor-induced arthralgia in breast cancer patients: A systematic review with network meta-analysis.

  2022cites this paper
• Incidence of antiepileptic drug therapy and factors associated with their prescribing in outpatients with diabetic polyneuropathy.

  2021cites this paper
• Chronic Pain Management in General and Hospital Practice

  2021cites this paper
• Effect of Spirulina (Spirulina platensis) on Blood Glucose Level and Renal Impairment in Diabetic Rats

  2021cites this paper
• Treatment of painful diabetic neuropathy

  2021cites this paper
• Advances About Immunoinflammatory Pathogenesis and Treatment in Diabetic Peripheral Neuropathy

  2021cites this paper
• Management of diabetic neuropathy.

  2021cites this paper
• The Treatment of Painful Diabetic Neuropathy.

  2021cites this paper
• Diabetic neuropathy: an insight on the transition from synthetic drugs to herbal therapies

  2021cites this paper
• Treatment of Painful Diabetic Neuropathy—A Narrative Review of Pharmacological and Interventional Approaches

  2021cites this paper
• Treatment of diabetic peripheral neuropathy: a review

  2020cites this paper
• New Perspective in Diabetic Neuropathy: From the Periphery to the Brain, a Call for Early Detection, and Precision Medicine

  2020cites this paper
• Neuropathic Pain Syndrome: Diabetic and Other Neuropathies

  2020cites this paper
• Oral Spirulina Platensis Attenuates Hyperglycemia and Exhibits Antinociceptive Effect in Streptozotocin-Induced Diabetic Neuropathy Rat Model

  2020cites this paper
• State-of-the-art pharmacotherapy for diabetic neuropathy

  2020cites this paper
• Current Strategies for the Management of Painful Diabetic Neuropathy

  2020cites this paper
• Diabetic Peripheral Neuropathy: Diagnosis and Treatment.

  2020cites this paper
• A data science approach to drug safety: Semantic and visual mining of adverse drug events from clinical trials of pain treatments

  2020cites this paper
• A Comparison of the Clinical Effectiveness of Specific Neurostimulation andPhotobiomodulation Modalities with Therapeutic Nutrition in the Treatmentof Peripheral Neuropathy

  2020cites this paper
• Treating Pain in Diabetic Neuropathy: Current and Developmental Drugs

  2020influential citation
• Guías ALAD basadas en evidencias para el diagnóstico y el tratamiento de la polineuropatía sensitivomotora diabética 2019 (Grupo NeuroALAD)

  2019cites this paper
• An update on the diagnosis and treatment of diabetic somatic and autonomic neuropathy

  2019cites this paper
• Efficacy of duloxetine and gabapentin in pain reduction in patients with knee osteoarthritis

  2019cites this paper
• Painful diabetic polyneuropathy: from clinical guidelines to daily practice

  2019cites this paper
• Repeat treatment with capsaicin 8% patch (179mg capsaicin cutaneous patch): Effects on pain, quality of life, and patient satisfaction in painful diabetic peripheral neuropathy: an open-label, randomized controlled clinical trial

  2019cites this paper
• Neuropathie bei Diabetes oft unerkannt — und auch im ZNS

  2018cites this paper
• Comparison of venlafaxine and duloxetine: measuring clinical impact of time to therapeutic dose (TTD) among patients achieving therapeutic dosing for pain

  2018cites this paper
• Diabetic Peripheral Neuropathy: Epidemiology, Diagnosis, and Pharmacotherapy.

  2018cites this paper
• Mirogabalin and emerging therapies for diabetic neuropathy

  2018cites this paper
• Use of antiepileptic mood stabilizers in dermatology.

  2018cites this paper
• Interventions for Neuropathic Pain: An Overview of Systematic Reviews

  2017cites this paper
• Real role of β-blockers in regression of left ventricular mass in hypertension patients

  2017cites this paper
• Actualización en el diagnóstico, tratamiento y prevención de la neuropatía diabética periférica

  2017cites this paper
• Clinical Pharmacology in India – A systematic review of research in the past 5 years

  2017cites this paper
• Bacosine isolated from aerial parts of Bacopa monnieri improves the neuronal dysfunction in Streptozotocin-induced diabetic neuropathy

  2017cites this paper
• Efficacy, Safety and Cost Effectiveness of Amitriptyline and Pregabalin in Patients with Diabetic Peripheral Neuropathy

  2017cites this paper
• Capsaicin 8% Patch Versus Oral Neuropathic Pain Medications for the Treatment of Painful Diabetic Peripheral Neuropathy: A Systematic Literature Review and Network Meta-analysis.

  2017cites this paper
• Alleviation of pain in painful diabetic neuropathy

  2016influential citation
• Diabetic neuropathy and painful diabetic neuropathy in the Middle East and North Africa (MENA) region: Much work needs to be done

  2016cites this paper
• Treatment of Diabetic Peripheral Neuropathy

  2016cites this paper
• Alpha2delta ligands, gabapentin, pregabalin and mirogabalin: a review of their clinical pharmacology and therapeutic use

  2016cites this paper
• Comparative Effectiveness of Blood Pressure-lowering Drugs in Patients who have Already Suffered From Stroke

  2016cites this paper
• An Observational Study on Lignocaine Infusion for Intractable Chronic Pain

  2016cites this paper
• Capsaicin 8% patch repeat treatment plus standard of care (SOC) versus SOC alone in painful diabetic peripheral neuropathy: a randomised, 52-week, open-label, safety study

  2016cites this paper
• Efficacy of venlafaxine XR for the treatment of pain in patients with spinal cord injury and major depression: a randomized, controlled trial.

  2015cites this paper
• CURSO DE ODONTOLOGIA

  2015cites this paper
• Levetiracetam synergises with common analgesics in producing antinociception in a mouse model of painful diabetic neuropathy.

  2015cites this paper
• Review of antidepressants in the treatment of neuropathic pain

  2015cites this paper
• Treating Diabetic Neuropathy: Present Strategies and Emerging Solutions.

  2015influential citation
• Treatment of painful diabetic neuropathy

  2015cites this paper
• Burning through the pain: treatments for diabetic neuropathy

  2015influential citation
• Amitriptyline Therapy in Chronic Pain

  2015cites this paper
• Preliminary results of a randomized controlled trial carried out with a fixed combination of S-adenosyl-L-methionine and betaine versus amitriptyline in patients with mild depression

  2015cites this paper
• THE USE OF TOPICAL CITRULLUS COLOCYNTHIS IN TREATMENT OF PAINFUL DIABETIC NEUROPATHY: A PILOT INTERVENTIONAL STUDY

  2014cites this paper
• Recent advances in the pharmacological management of acute and chronic pain.

  2014cites this paper
• Clinical experience with desvenlafaxine in treatment of pain associated with diabetic peripheral neuropathy

  2014cites this paper
• Assessment and management of chronic pain in patients with depression and anxiety

  2014cites this paper
• For peer review only Management of chronic neuropathic pain: a protocol for a multiple treatment comparison meta-analysis of randomized controlled trials

  2014cites this paper
• Pregabalin: a guide to its use in fibromyalgia, neuropathic pain and generalized anxiety disorder

  2014influential citation
• Face-to-face comparison of the predictive validity of two models of neuropathic pain in the rat: analgesic activity of pregabalin, tramadol and duloxetine.

  2014cites this paper